View in EDS

Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence.

Saved in:
Bibliographic Details
Title: Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence.
Authors: Sanyal AJ; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA., Kowdley KV; Department of Gastroenterology and Hepatology, Elson Floyd College of Medicine, Spokane, Washington, USA., Reau NS; Department of Medicine, Rush University, Chicago, Illinois, USA., Pyrsopoulos NT; Rutgers New Jersey Medical School, Newark, New Jersey, USA., Allen C; Salix Pharmaceuticals, Bridgewater, New Jersey, USA., Heimanson Z; Salix Pharmaceuticals, Bridgewater, New Jersey, USA., Bajaj JS; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA.; Central Virginia Veterans Healthcare System, Richmond, Virginia, USA.
Source: Hepatology communications [Hepatol Commun] 2024 May 10; Vol. 8 (6). Date of Electronic Publication: 2024 May 10 (Print Publication: 2024).
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Clinical Trial, Phase III; Clinical Trial, Phase IV
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38727685
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sanyal+AJ%22">Sanyal AJ</searchLink>; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Kowdley+KV%22">Kowdley KV</searchLink>; Department of Gastroenterology and Hepatology, Elson Floyd College of Medicine, Spokane, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Reau+NS%22">Reau NS</searchLink>; Department of Medicine, Rush University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Pyrsopoulos+NT%22">Pyrsopoulos NT</searchLink>; Rutgers New Jersey Medical School, Newark, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Allen+C%22">Allen C</searchLink>; Salix Pharmaceuticals, Bridgewater, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Heimanson+Z%22">Heimanson Z</searchLink>; Salix Pharmaceuticals, Bridgewater, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Bajaj+JS%22">Bajaj JS</searchLink>; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA.; Central Virginia Veterans Healthcare System, Richmond, Virginia, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101695860%22">Hepatology communications</searchLink> [Hepatol Commun] 2024 May 10; Vol. 8 (6). <i>Date of Electronic Publication: </i>2024 May 10 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Clinical Trial, Phase III; Clinical Trial, Phase IV
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101695860 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2471-254X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222471254X%22">2471254X </searchLink><i>NLM ISO Abbreviation: </i>Hepatol Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38727685
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/HC9.0000000000000436
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sanyal AJ
      – PersonEntity:
          Name:
            NameFull: Kowdley KV
      – PersonEntity:
          Name:
            NameFull: Reau NS
      – PersonEntity:
          Name:
            NameFull: Pyrsopoulos NT
      – PersonEntity:
          Name:
            NameFull: Allen C
      – PersonEntity:
          Name:
            NameFull: Heimanson Z
      – PersonEntity:
          Name:
            NameFull: Bajaj JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 05
              Text: 2024 May 10
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2471-254X
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Hepatology communications
              Type: main
ResultId 1